Yucheng Lu | Neuroscience | Research Excellence Award

Prof. Yucheng Lu | Neuroscience | Research Excellence Award

Linyi People's Hospital | China

Prof. Yucheng Lu is a distinguished researcher whose scholarly contributions span cancer biology, immunology, and translational biomedical sciences. With 352 citations, 26 indexed publications, and an h-index of 13, he has established a strong research footprint in molecular oncology and disease pathology. Over his academic career, he has published 40 peer-reviewed papers, including 25 as first or corresponding author, reflecting consistent leadership in scientific inquiry. His work encompasses cutting-edge topics such as tumor-associated macrophage regulation in glioma, prognostic biomarkers in low-grade glioma, colorectal cancer therapeutics, and single-cell transcriptomics in esophageal cancer. In addition, he has explored metabolic and immunological disease interactions, cancer proliferation mechanisms, and neural electrophysiological responses. As a principal investigator, he has led 7 provincial and municipal research projects and contributed to 8 national and ministerial-level initiatives, demonstrating strong project management and interdisciplinary collaboration. His research excellence has earned 3 Science and Technology Achievement Awards, alongside innovations represented by 1 invention patent and 6 software copyrights. Through these achievements, Prof. Lu continues to advance biomedical research with significant scientific, clinical, and technological impact.

Profile : Scopus | Orcid

Featured Publications

Shi, H., Cheng, Y., Chao, D., Song, Q., Han, L., Li, H., Lu, Y., & Wang, M. (2025). Spatiotemporal profiling of endocytic regulators in the immunosuppressive TAM microenvironment of glioma. Brain Research, 150086. (In press)

Author names not provided. (2025). Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma. Scientific Reports.

Author names not provided. (2025). Okanin suppresses the growth of colorectal cancer cells by targeting Peroxiredoxin 5. Advanced Science.

Shi, K., Li, Y., Yang, L., Zhang, Z., Guo, D., Zhang, J., & Lu, Y. (2022). Profiling transcriptional heterogeneity of epithelium, fibroblasts, and immune cells in esophageal squamous cell carcinoma by single-cell RNA sequencing. The FASEB Journal, 0892-6638.

Zhao, J. Z., Lu, Y. C., Wang, Y. M., Xiao, B. L., Li, H. Y., Lee, S. C., & Wang, L. J. (2022). Association between diabetes and acute lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma. International Journal of Diabetes in Developing Countries, 0973-3930.

Shi, K., Zhang, J. Z., Yang, L., Li, N. N., Yue, Y., Du, X. H., Zhang, X. Z., Lu, Y. C., & Guo, D. (2021). Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma. BMC Cancer, 1471-2407.

Lu, Y., Lv, B., & Song, Q. (2019). Transcranial electrical stimulation motor-evoked potentials in a spinal cord ischaemia rabbit model. Chinese Neurosurgical Journal, 2057-4967.

Lu, Y. C., Wang, P., Wang, J., Ma, R., & Lee, S. C. (2019). PCNA and JNK1-Stat3 pathways respectively promote and inhibit diabetes-associated centrosome amplification by targeting the ROCK1/14-3-3σ complex in human colon cancer HCT116 cells. Journal of Cellular Physiology.

Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr. Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Insubria | Italy

Dr. Annalisa Bosi is a distinguished researcher with 909 citations, 29 scientific documents, and an h-index of 15, reflecting her strong impact in the fields of immunology, gastrointestinal pathology, and microbiota–gut–brain axis research. Her early work focused on the phenotypic and functional characterization of innate immune components, particularly NK cells and macrophages, examining their role in tumor pathogenesis and their modulation by chemotherapeutic agents or plant-derived molecules. She later advanced her research to explore molecular and cellular mechanisms underlying major gastrointestinal diseases such as ischemia, intestinal inflammation, and enteric neuropathy, identifying the regulatory role of hyaluronic acid homeostasis in tissue repair. Her recent studies investigate gut microbiota, dysbiosis, and their influence on neurodevelopment and tumor etiopathogenesis, with growing emphasis on prebiotic and probiotic interventions. Dr. Bosi has contributed significantly to understanding experimental models of gut pathology, neuromuscular dysfunction, immunomodulation by virome components, and sex-dependent microbial effects. Her publications span high-impact journals, covering topics such as microbiota–immune interactions, ischemia–reperfusion injury, cytokine–phage crosstalk, and neuroimmune modulation. Through multidisciplinary approaches integrating molecular biology, immunology, and neurogastroenterology, her work continues to shape emerging perspectives on host–microbiota communication and its relevance to disease mechanisms and therapeutic strategies.

Profiles : Scopus | Orcid

Featured Publications

Bosi, A., Baranzini, N., Ponti, A., Moretto, P., Moro, E., Crema, F., Cianci, R., Karousou, E., Viola, M., Passi, A., et al. (2025). Intestinal ischemia/reperfusion injury influences hyaluronan homeostasis in the rat brain. International Journal of Molecular Sciences, 26(20), 10064.

Cianci, R., Caldarelli, M., Brani, P., Bosi, A., Ponti, A., Giaroni, C., & Baj, A. (2025). Cytokines meet phages: A revolutionary pathway to modulating immunity and microbial balance. Biomedicines, 13(5), 1202.

Faggin, S., Cerantola, S., Caputi, V., Tietto, A., Stocco, E., Bosi, A., Ponti, A., Bertazzo, A., Macchi, V., Porzionato, A., et al. (2025). Toll-like receptor 4 deficiency ameliorates experimental ileitis and enteric neuropathy: Involvement of nitrergic and 5-hydroxytryptaminergic neurotransmission. British Journal of Pharmacology, 182(8), 1803–1822.

Brani, P., Manzoor, H. Z., Spezia, P. G., Vigezzi, A., Ietto, G., Dalla Gasperina, D., Minosse, C., Bosi, A., Giaroni, C., Carcano, G., et al. (2025). Torque Teno Virus: Lights and shades. Viruses, 17(3), 334.

Dal Lago, S., Brani, P., Ietto, G., Dalla Gasperina, D., Gianfagna, F., Giaroni, C., Bosi, A., Drago Ferrante, F., Genoni, A., Manzoor, H. Z., et al. (2024). Torque Teno Virus: A promising biomarker in kidney transplant recipients. International Journal of Molecular Sciences, 25(14), 7744.

Giambra, V., Pagliari, D., Rio, P., Totti, B., Di Nunzio, C., Bosi, A., Giaroni, C., Gasbarrini, A., Gambassi, G., & Cianci, R. (2023). Gut microbiota, inflammatory bowel disease, and cancer: The role of guardians of innate immunity. Cells, 12(22), 2654.

Bosi, A., Banfi, D., Bistoletti, M., Catizzone, L. M., Chiaravalli, A. M., Moretto, P., Moro, E., Karousou, E., Viola, M., Giron, M. C., et al. (2022). Hyaluronan regulates neuronal and immune function in the rat small intestine and colonic microbiota after ischemic/reperfusion injury. Cells, 11(21), 3370.

Bosi, A., Banfi, D., Bistoletti, M., Moretto, P., Moro, E., Crema, F., Maggi, F., Karousou, E., Viola, M., Passi, A., et al. (2021). Hyaluronan: A neuroimmune modulator in the microbiota–gut axis. Cells, 11(1), 126.

Cerantola, S., Caputi, V., Contarini, G., Mereu, M., Bertazzo, A., Bosi, A., Banfi, D., Mantini, D., Giaroni, C., & Giron, M. C. (2021). Dopamine transporter genetic reduction induces morpho-functional changes in the enteric nervous system. Biomedicines, 9(5), 465.

Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021). Impact of microbial metabolites on microbiota–gut–brain axis in inflammatory bowel disease. International Journal of Molecular Sciences, 22(4), 1623.

Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020). Innate immunity effector cells as inflammatory drivers of cardiac fibrosis. International Journal of Molecular Sciences, 21(19), 7165.

Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A., Bruno, A., & Mortara, L. (2020). The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: A focus on innate immunity cells as therapeutic effectors. International Journal of Molecular Sciences, 21(9), 3125.

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020). Tryptophan metabolites along the microbiota–gut–brain axis: An interkingdom communication system influencing the gut in health and disease. International Journal of Tryptophan Research, 13, 1–18.

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

 

Publications


📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025


📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025


📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024


📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024


📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024


Hyun Min Kim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Hyun Min Kim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Duke Kunshan University | China

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Hyun Min Kim's journey in the scientific realm began with a Bachelor of Science in Life Science from Hanyang University, Seoul, South Korea, in 1997. This foundational phase nurtured his interest in microbiology, leading to a Master of Science in Life Science (Microbiology) from the same institution in 1999. His academic ascent culminated in a Ph.D. in Applied Biology (Genetics and Molecular Cell Biology) at Georgia Institute of Technology, USA, in 2009, where he explored genome instability, tri-nucleotide repeats, and their genetic implications. This solid academic grounding propelled him toward groundbreaking discoveries.

👨‍🔬 Professional Endeavors

Prof. Kim’s illustrious career spans continents and decades, beginning as a Chief Research Scientist at Hanyang University Medical School, focusing on cytokine profiling and toll-like receptor proteins. His time as a Research Assistant and later a Post-doctoral Fellow at Harvard Medical School cemented his expertise in genome editing and DNA damage repair mechanisms.
His roles as Associate Professor at Tianjin University and Duke Kunshan University underscore his contributions to epigenetics and the development of CRISPR-Cas9 systems. Currently, he serves as an Associate Professor of the Practice at Duke University, advancing molecular biology through cutting-edge research on histone demethylases and DNA damage repair.

🔬 Contributions and Research Focus

Prof. Kim's research revolves around epigenetic regulation and genome editing. He has made pivotal contributions to understanding histone demethylases' roles in DNA damage repair and cancer pathways. His work on CRISPR-Cas9 has refined genome editing techniques, particularly in C. elegans, enabling advances in genetic and therapeutic research. His publications, spanning high-impact journals like Biomolecules, Frontiers in Genetics, and Nature Communications, highlight his dedication to elucidating molecular mechanisms influencing genetic stability and cancer development.

🏆 Accolades and Recognition

Prof. Kim's academic excellence has been consistently recognized. From early scholarships at Hanyang University to the prestigious Sarstedt® Graduate Student Award for his Ph.D. accomplishments, his journey is marked by accolades. He received the Faculty Teaching Award at Tianjin University and multiple travel and mentorship awards, showcasing his dual strengths as a researcher and educator. His innovative work has also attracted significant funding, including grants from the National Natural Science Foundation of China and the Kunshan Shuangchuang Grant, totaling millions in support for his transformative projects.

🌟 Impact and Influence

Prof. Kim's efforts have shaped the scientific and academic communities. His leadership roles, such as organizing journal clubs at Harvard Medical School and contributing to editorial boards like Life Journal and Jove Journal, underscore his influence. As a mentor, he has guided budding researchers and students, exemplified by his award for mentoring undergraduates at Georgia Tech. His findings in genome stability, CRISPR-Cas9, and epigenetics continue to inspire advancements in genetic engineering and cancer therapy.

✨ Legacy and Future Contributions

With an eye on the future, Prof. Kim remains committed to unraveling the mysteries of molecular genetics and epigenetics. His work lays a foundation for next-generation cancer therapeutics and genome editing platforms. As a leader in both teaching and research, his legacy will undoubtedly endure, fostering innovation and collaboration in life sciences globally.

 

Publications


📄 Torenia sp. Extracts Contain Multiple Potent Antitumor Compounds with Nematocidal Activity, Triggering an Activated DNA Damage Checkpoint and Defective Meiotic Progression

  • Author: Meng, Q., Borris, R.P., Kim, H.-M.
  • Journal: Pharmaceuticals
  • Year: 2024

📄 Exploring the Impact of Onobrychis cornuta and Veratrum lobelianum Extracts on C. elegans: Implications for MAPK Modulation, Germline Development, and Antitumor Properties

  • Author: Meng, Q., Pathak, N., Ren, X., Borris, R.P., Kim, H.-M.
  • Journal: Nutrients
  • Year: 2024

📖 LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond

  • Author: Kim, H.-M., Liu, Z.
  • Journal: Biomolecules
  • Year: 2024

📖 Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression

  • Author: Kim, H.-M., Zheng, X., Lee, E.
  • Journal: International Journal of Molecular Sciences,
  • Year:  2023

📖 A Decade of CRISPR-Cas Genome Editing in C. elegans

  • Author: Kim, H.-M., Hong, Y., Chen, J.
  • Journal:  International Journal of Molecular Sciences
  • Year:  2022

 

Vijayalakshmi Venkatesan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Vijayalakshmi Venkatesan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Regenerative Research Sciences Private Limited | India

Author profile

Scopus

Early Academic Pursuits

Dr. Vijayalakshmi Venkatesan began her academic journey with a B.Sc. in Botany, Zoology, and Chemistry, achieving First Class with Distinction. She pursued her passion further with an M.Sc. in Biochemistry, securing the second rank in the university. Her academic pursuit culminated in a Ph.D. in Biochemistry from the National Institute of Nutrition/Osmania University. Following this, she engaged in postdoctoral research at the Centre for Cellular and Molecular Biology.

Professional Endeavors

Dr. Vijayalakshmi Venkatesan's professional journey has been marked by significant roles in academia and research. She served as the Director-Grade Scientist and Head of Cell & Molecular Biology and Stem Cell Research at the National Institute of Nutrition, ICMR, Hyderabad. Currently, she holds the position of Director-Research at Movva Health Care LLP, RegenOrthoSport, where she continues to contribute to cutting-edge research in biochemistry and stem cell research.

Contributions and Research Focus

Her research focuses on regenerative medicine, particularly in addressing non-communicable diseases (NCDs) like diabetes, obesity, and knee osteoarthritis. Dr. Vijayalakshmi Venkatesan's work involves understanding the pathophysiology of these diseases at the cellular and molecular levels. She has made significant strides in the isolation, characterization, and therapeutic application of mesenchymal stem cells (MSCs) derived from various sources, including placenta and bone marrow. Additionally, her research explores the potential of nutraceuticals in managing these conditions, highlighting the beneficial effects of compounds like stigmasterol, gingerol, and shogaol.

Accolades and Recognition

Dr. Vijayalakshmi Venkatesan's contributions to the field have been recognized through numerous awards and honors. She has been felicitated with awards such as the Woman of Excellence Award, Venus International Award for Excellence in Biochemistry and Stem Cell Research, and the Dr. S.N. Acharya Felicitation Award. Her expertise has also earned her fellowship status in prestigious organizations like the National Academy of Medical Sciences and the Telangana Academy of Sciences.

Impact and Influence

Dr. Vijayalakshmi Venkatesan's research has left a significant impact on both academia and clinical practice. Her findings have been published extensively in peer-reviewed journals, with over 100 scientific articles and several book chapters to her credit. She has also been granted multiple patents for her innovative research in liver cell therapy and mesenchymal stem cell transplantation. Moreover, she actively participates in various professional societies and serves on the editorial boards of esteemed journals in the field.

Legacy and Future Contributions

Dr. Vijayalakshmi Venkatesan's legacy lies in her pioneering work at the intersection of biochemistry, genetics, and regenerative medicine. Her ongoing efforts in translational research aim to bridge the gap between laboratory discoveries and clinical applications, with a focus on improving healthcare outcomes for patients with metabolic disorders and musculoskeletal conditions. As she continues to lead research initiatives and mentor future scientists, her contributions are poised to shape the future of regenerative medicine and personalized healthcare.

Notable Publications

Alleviation of diabetes mellitus through the restoration of β-cell function and lipid metabolism by Aloe vera (L.) Burm. f. extract in obesogenic WNIN/GR-Ob rats  2021 (19)

Elevated ATP, cytokines and potential microglial inflammation distinguish exfoliation glaucoma from exfoliation syndrome 2022 (7)

The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study 2017 (10)